Skip to content

Main Navigation

The Vaccine Confidence Project
  • Home
  • Our Work
    • All work
    • Projects
    • Publications
    • Reports
    • Briefings & Guidance
    • Data Visualisations
  • Index
    • Vaccine Confidence Index Map
    • Data & Methodolgy
  • About
    • Who We Are
    • Theory of Change
    • Strategy
    • Partnerships
    • The Team
    • FAQ
  • News
    • Latest News
    • Media & Commentary
    • Video & Events
    • Podcasts
  • Get Involved
  • For Media
  • Contact Us
  • All work
  • Projects
  • Publications
  • Reports
  • Briefings & Guidance
  • Data Visualisations

HIV/STI Prevention for Young People in the EU and Africa

Vaccine Confidence Project logo
European Centre for Disease Control and Prevention logo
LVCT Kenya logo
The Bill & Melinda Gates Foundation logo
London School of Hygiene & Tropical Medicine logo

Overview

The Vaccine Confidence Project™ has engaged in several different research projects relating to the prevention of HIV and other STIs.

In the context of consistently high rates of STIs and increasing numbers of new HIV infections in young people), four different strands of research were developed by our team in partnership with the European Centre for Disease Control (ECDC), seeking to identify the best ways to prevent the spread of HIV/STI among young people in Europe.

The VCP team at the London School of Hygiene & Tropical Medicine also researched HIV risk perception in sub-Saharan Africa and the feasibility and acceptability of PrEP in Kenya in partnership with LVCT, Kenya.

This PrEP research was funded by the Bill & Melinda Gates Foundation.

Methods

Europe

  1. Systematic Review of interventions aimed at preventing HIV and STIs in young people in Europe: collating effective evidence-based interventions that could contribute to HIV/STI prevention among young people in the EU/EEA by identifying and assessing relevant systematic reviews or meta-analyses of efficacy and/or effectiveness of interventions aimed at preventing HIV and STIs in young people in EU/EEA;
  2. Grey literature Review: conduct a comprehensive search of the grey literature for the same evidence as cited above;
  3. Literature Review: use of digital media technology for primary and secondary prevention of HIV/STIs among European Youth (2010-2015): Conduct a literature review of the most recent published evidence on the use of digital media technologies for the prevention of STIs/HIV in young people living Europe (2010-2016) (restricted to EU/EFTA countries only). This systematic literature review seeks to: 1) identify current activities using digital technologies for prevention of HIV and sexually transmitted infections (STIs); 2) gauge effectiveness in relation to user behaviour (e.g, uptake), cognitive changes (e.g., knowledge/attitudes) and biological outcomes (e.g., infection rates), based on available data, and 3) discuss the relevance of digital applications to deliver sexual health prevention to young people;
  4. Handbook for preventing HIV/STI among you in Europe using social media: to create a handbook of basic principles and approaches regarding the use of selected social media to promote prevention of HIV and other sexually transmitted infections (STI) among youth across Europe. We understand ‘social media’ to be the websites and applications which allow users to connect with others, create and share content and engage in social networking. The approaches described in the handbook will include guidance on how to map social media trends, monitor usage, identify social influencers, inform HIV/STI prevention strategies and engage young people in Europe.

Africa

Qualitative research on Pre-exposure prophylaxis (PrEP) for HIV prevention

Objectives:

  1. To understand how people’s understanding of risk and uncertainty affects their ability to use and adhere to biomedical prevention interventions within their daily lives.
  2. To support the roll out of PrEP and its integration within existing combination prevention approaches in Kenya and South Africa.

Pre-exposure prophylaxis (PrEP) clinical trials and effectiveness studies have shown that PrEP works in the prevention of HIV if taken consistently. However, there have been issues with adherence identified in these studies.

Previous research on risk has focused on classifying people or behaviours into risk categories. Our work diverges from that tradition and seeks to understand how people’s daily lives form a context in which choices are made and values balanced. Therefore we try to understand where HIV prevention fits into a hierarchy of concerns.

With this anthropological lens, we provide technical assistance and capacity building with partner organisations in Kenya in South Africa where PrEP is currently being rolled-out among “high-risk” populations. Focusing on the analysis, interpretation, and dissemination of qualitative findings, we seek to understand the meaning and significance of emerging interventions in people’s lives so that they can be made more acceptable through the eventual health systems rollout.

The team is also carrying out 2 systematic reviews. The first is on conceptualizations of uncertainty and risk, and implications for uptake and use of biomedical HIV prevention technologies in sub-Saharan Africa. The second review is on motivations and barriers to HIV prevention uptake and use by women in sub-Saharan Africa.

Related content

Reports
Utilising social media to support HIV/STI prevention: evidence to inform a handbook for public health agency managers

This report frames social media as an important tool not only to communicate, but also to monitor topics of discussion, prevalent sentiments, and define the characteristics of social networks among young people around different topics.

Reports
Utilising social media for HIV/STI prevention programmes among young people: A handbook for public health programme managers

The target audience for this handbook includes public health programme managers working on and with STI/HIV prevention programmes for young people in EU/EEA countries.

Publications
Risk perception and the influence on uptake and use of biomedical prevention interventions for HIV in sub-Saharan Africa: A systematic literature review

This systematic review of qualitative peer-reviewed literature from…

Publications
Motivations and barriers to uptake and use of female-initiated, biomedical HIV prevention products in sub-Saharan Africa: an adapted meta-ethnography

Women bear a disproportionate burden of HIV throughout the world prompting…

Projects
Developing effective digital communications strategies for driving HPV vaccine uptake in Japan, Korea, and China

This research applies communication and behavioural theories to comprehensively assess confidence in and acceptance of HPV vaccines in Japan, Korea, and China amongst people who have not received the vaccine, in order to develop effective digital communication strategies to increase uptake.

Projects
Building Confidence in Routine Immunisation

The UNICEF Regional Office for Europe and Central Asia (UNICEF ECARO) and the VCP worked in partnership to better understand the impact of social media on caregivers’ attitudes, beliefs, trust, immunisation intention and uptake.

Summary

Project date:

2017 - 2019

Topics:
  • Region - Europe
  • Social
  • Region - Africa
  • HIV
  • STIs
  • Literature Reviews
  • Qualitative Research
  • Intervention Development
  • Social Media
  • Risk Communications
Team leads
  • Clarissa Simas
Key partners
  • European Centre for Disease Control and Prevention
  • The Bill & Melinda Gates Foundation
  • LVCT Kenya

Latest content

Publications
A vaccine chatbot intervention for parents to improve HPV vaccination uptake among middle school girls: a cluster randomized trial

This study assesses the effectiveness of a vaccine chatbot in improving human papillomavirus (HPV) vaccination among female middle school students aged 12–15 years across diverse socioeconomic settings in China, where HPV vaccination is primarily paid out-of-pocket.

Publications
Mapping global public perspectives on mRNA vaccines and therapeutics

We conducted a social listening analysis to assess attitudes towards mRNA vaccines and therapeutics on Twitter from June 2022 to May 2023. Our findings reveal widespread negative sentiment and a global lack of confidence in mRNA vaccines and therapeutics, with frequent discussions of severe vaccine side effects, rumors, and misinformation.

Data Visualisations
Mapping global public perspectives on Health AI

We conducted a social listening analysis to assess attitudes towards Health AI.

Regional offices:
Quick Links
  • Who we are
  • Our work
  • News
  • Partnerships
  • Privacy Policy & Cookies
  • Terms of Use
  • Image credits
Get in touch
  • Contact Us
  • Partnerships
Follow us
Subscribe
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}